Recent Quotes (30 days)

You have no recent quotes
chg | %

Kalytera Therapeutics Inc  

(Public, CVE:KALY)   Watch this stock  
0.120
0.000 (0.00%)
Sep 20 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.12 - 0.12
52 week 0.10 - 1.60
Open 0.12
Vol / Avg. 255,144.00/260,590.00
Mkt cap 15.09M
P/E     -
Div/yield     -
EPS -0.21
Shares 129.24M
Beta 31.56
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -40.63% -478.33%
Return on average equity -44.60% -1294.00%
CDP Score - -

Address

The Exchange Tower 130 King St W Suite 2210
TORONTO, ON M5X 2A2
Canada
+1-416-3624441 (Phone)
+1-403-2668647 (Fax)

Description

Kalytera Therapeutics Inc, formerly Santa Maria Petroleum Inc. is a Canada-based company, engaged in the development of cannabinoid (CBD) therapeutics. The Company is developing CBD formulations and prodrugs to target specific disease sites within the body. The Company's development programs include Bone Fracture Healing, Osteogenesis Imperfecta, Osteoporosis and Osteoporosis in Prader-Willi syndrome (PWS). The Company is focused on the development of KAL436/9, which is a synthetic derivative of CBD that has been structurally modified to develop solubility in water to improve potency. Its KAL671 is a synthetic fatty acid amide and an endocannabinoid-like molecule that may restore bone in persons suffering from osteoporosis. The Company's researchers are exploring the ability for KAL671 to prevent bone loss in mice with genetic mutations designed to mimic aspects of PWS.

Officers and directors

Ronald P. Erickson Interim Chairman of the Board
Robert E. Farrell J.D. President, Interim Chief Executive Officer, Chief Financial Officer
Age: 66
Mike Dai Chief Financial Officer, Director
David Bassa Chief Operating Officer
Age: 55
Sari Prutchi-Sagiv Ph.D. Chief Scientific Officer
Moshe Yeshurun M.D. Chief Medical Officer
Pini Ben-Elazar Director
Michael Galloro Director
Scott R. Cochlan Independent Director
Douglas G. Manner Independent Director
Age: 56